US 11976293
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies
granted A61KA61K35/28A61K48/005
Quick answer
US patent 11976293 (Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies) held by The Regents of the University of California expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/28, A61K48/005, A61P, A61P7/00